Oculera is a health-tech startup that builds virtual-reality-powered solutions for eye-care and neurological screening. Its CE-certified platform delivers non-invasive diagnostics and has been adopted in over 20 countries, demonstrating early international traction. By pairing VR hardware with proprietary software, the company targets faster, more accessible detection of ocular and neurological disorders in clinics and remote settings. The newly secured $3 million investment will be directed toward product refinement, regulatory expansion and broader global commercialization. Although detailed revenue figures were not shared, the widespread clinical deployment signals growing market acceptance. Management plans to leverage the fresh capital to scale manufacturing, enhance its diagnostic algorithms and forge additional partnerships with healthcare providers.

Total raised

$3M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2025